SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject10/22/2002 4:23:43 PM
From: scaram(o)uche   of 598
 
United States Patent Application 20020150934
Kind Code A1
Powers, Scott ; et al. October 17, 2002

--------------------------------------------------------------------------------
Diagnosis and treatment of cancer using mammalian pellino polypeptides and polynucleotides

Abstract
The present invention provides methods, reagents, and kits for diagnosing and treating cancer in a mammal, e.g., a human. This invention is based upon the discovery that Pellino 1 or 2 is overexpressed and/or amplified in cancer. Methods to detect cancer or a propensity to develop cancer, to monitor the efficacy of a cancer treatment, and to treat cancer, by inhibiting the expression and/or activity of Pellino 1 or 2 in a cancer cell are included.

Inventors: Powers, Scott; (Greenlawn, NY) ; Mu, David; (Jericho, NY) ; Xiang, Phil; (San Francisco, CA) ; Peng, Yue; (South Setauket, NY)
Correspondence Name and Address: TOWNSEND AND TOWNSEND AND CREW, LLP
TWO EMBARCADERO CENTER
EIGHTH FLOOR
SAN FRANCISCO
CA
94111-3834
US


Assignee Name and Adress: Tularik Inc.
South San Francisco
CA
94080


Serial No.: 041030
Series Code: 10
Filed: December 28, 2001
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext